UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034021
Receipt number R000038709
Scientific Title The relationship between pathogenesis of irritable bowel syndrome and microbiome
Date of disclosure of the study information 2018/09/13
Last modified on 2018/09/13 17:17:21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The relationship between pathogenesis of irritable bowel syndrome and microbiome

Acronym

irritable bowel syndrome and microbiome

Scientific Title

The relationship between pathogenesis of irritable bowel syndrome and microbiome

Scientific Title:Acronym

irritable bowel syndrome and microbiome

Region

Japan


Condition

Condition

irritable bowel syndrome

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To compare microbiome between patients with irritable bowel syndrome and healthy controls. To investigate relationships between microbiome and symptoms or QOL scores of patients with IBS.

Basic objectives2

Others

Basic objectives -Others

To compare prevalence of food hypersensitibity or serum cytokine profile between patients with irritable bowel syndrome and healthy controls.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Diversity of microbiome

Key secondary outcomes

Prevalence of food hypersensitivity.
Serum cytokine profile


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with irritable bowel syndrome. Healthy controls.

Key exclusion criteria

Patients with systemic inflanmatoris disease. Patients with malignant disorders.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akiko Shiotani

Organization

Kawasaki Medical School

Division name

Gastroenterology

Zip code


Address

577 Matsusima, Kurashiki city, Okayama, Japan

TEL

086-462-1111

Email

shiotani@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Akiko Shiotani

Organization

Kawasaki Medical School

Division name

Gastroenterology

Zip code


Address

577 Matsusima, Kurashiki city, Okayama, Japan

TEL

086-462-1111

Homepage URL


Email

shiotani@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

Self sustaining

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

川崎医科大学附属病院


Other administrative information

Date of disclosure of the study information

2018 Year 09 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 09 Month 13 Day

Date of IRB


Anticipated trial start date

2018 Year 09 Month 13 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2018 Year 09 Month 04 Day

Last modified on

2018 Year 09 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038709


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name